2018 Fourth quarter stock market review
Interviewee/Contributor
William Ellington
Organisation
MedNous
Research Directory
Exscientia raises $26 million, partners with Roche
Interviewee/ContributorAndrew HopkinsOrganisationExscientia LtdIMI: Building a science infrastructure for Europe
Interviewee/ContributorPierre MeulienOrganisationInnovative Medicines InitiativeDesigning trials for allergy product development
Interviewee/ContributorVincent CharlonOrganisationAnergis SAA strategy for using AI in pharma R&D
Interviewee/ContributorEd CorbettOrganisationNovasecta LtdProducing viral vectors on an industrial scale
Interviewee/ContributorNicole FaustOrganisationCEVEC Pharmaceuticals GmbHDeveloping gene therapies: a manufacturing view
Interviewee/ContributorMadhusudan PeshwaOrganisationGE HealthcareNovartis sets out its vision for pharma R&D
Interviewee/ContributorRobin DavisonOrganisationNew Science Global Healthcare FundLight on the horizon for Swedish biopharma
Interviewee/ContributorSøren TulstrupOrganisationHansa Medical ABGalecto raises €79 million in Series C round
Interviewee/ContributorKaren WagnerOrganisationYsios Capital